Streetbeat News

Stock Prices

ALKS

Over the past three months, 7 analysts have shared their evaluations of Alkermes (NASDAQ:ALKS), revealing a range of outlooks from bullish to bearish. The average 12-month price target is $39.43, with a high of $50.00 and a low of $34.00. Recent analyst actions include upgrades and maintained ratings, reflecting evolving market conditions and company performance.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:01 pm

HLIT

Over the past three months, five analysts have evaluated Harmonic (NASDAQ:HLIT), all maintaining a bullish stance. The average 12-month price target remains at $18.00. Despite a 22.57% decline in revenue growth, Harmonic shows strong net margins and efficient asset use, though it struggles with ROE.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:01 pm

KYMR

Analysts have provided mixed ratings for Kymera Therapeutics (NASDAQ:KYMR) over the past three months, with a majority being bullish. The average 12-month price target has increased slightly to $48.6. Financial metrics show positive revenue growth but challenges in ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:01 pm

BBY

Best Buy Co (NYSE:BBY) has been analyzed by 12 analysts over the past three months, showing a range of perspectives from bullish to bearish. The average 12-month price target has increased to $92.92 from $85.58. Analysts have recently adjusted their ratings and price targets, with several raising their targets. Best Buy's financials show a decline in revenue growth but strong net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:00 pm

BBY

Best Buy shares are trading higher following an upgrade from UBS, which raised the stock rating from Neutral to Buy and increased the price target from $85 to $106.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:54 am

HBIO

HLLY

SYPR

Insiders are buying shares of Harvard Bioscience, Sypris Solutions, and Holley, indicating confidence in these companies. Notable transactions include purchases by executives and directors, with Harvard Bioscience facing weaker-than-expected sales, Sypris Solutions appointing a new VP, and Holley receiving an Outperform rating from Telsey Advisory Group.

Portfolio Pulse from Avi Kapoor

June 17, 2024 | 11:51 am

IPW

iPower shares are trading lower following the announcement of a registered direct offering of $5 million.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:51 am

IPW

iPower Inc. (IPW) has announced a registered direct offering of 2.08 million shares of its common stock at a price of $2.40 per share.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:50 am

STLD

Steel Dynamics shares are trading lower after the company issued Q2 guidance below estimates.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:49 am

STLD

Steel Dynamics has provided Q2 EPS guidance of $2.64 - $2.68, which is below the estimated $2.97 and significantly lower than the $3.67 in Q1 and $4.81 last year. The company's steel operations profitability is expected to be lower due to reduced pricing, despite steady shipments. Domestic steel demand remains strong, led by the automotive, non-residential construction, energy, and industrial sectors, but buying hesitancy has emerged due to a weakening scrap price environment.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 11:48 am